Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b

Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b

Hepatitis C virus (HCV) intergenotype recombinant form (RF) 2k/1b has been actively circulating in HCV‐infected patients, and the prevalence of this RF virus in the Republic of Georgia is one of the highest reported worldwide. The aim of this study was to define the optimal treatment regimen for patients with RF_2k/1b.

Read Article


Metadata